To deliver functional predictive assays of patient responses to oncology therapeutics

  • Company foundation based on extensive research and translational studies at Dana-Farber
  • Patented technology from Dana-Farber & MIT
    Exclusively licensed to Xsphera Biosciences
  • Founded in 2018
    Early-stage venture backing
  • Primary focus on drug development platform
    Ultimately also enabling functional precision medicine
  • Deep commitment to IP and human capital
    Building a leading research & development team
Xsphera headquarters in Boston, MA, Seaport District. Image courtesy of Related Beal.